International Journal of Tuberculosis and Lung Disease

The IJTLD is the official publication of The Union, and the leading peer-reviewed journal dedicated to lung health worldwide.

You are here:

IJTLD

TB remains one of the world’s deadliest infectious diseases.

We believe we will only make progress in ending TB if we are led by the science and we communicate new knowledge clearly and effectively. Our Journal is designed with this in mind and we invite you to join our growing readership.

A subscription provides unrestricted access to Original Articles, Reviews, Editorials, Letters and Correspondence – and the IJTLD Clinical Standards for Lung Health. Coverage focuses on TB, but also advances our understanding of COVID-19, respiratory diseases such as asthma and COPD, and the hazards of tobacco and air pollution.

Individuals can subscribe to the IJTLD online or in print, or please ask your librarian to contact us (see link for further details).

The IJTLD Clinical Standards

We recently launched the IJTLD Clinical Standards for Lung Health, for optimal management of patients.

Thanks to the support of the Oskar-Helene-Heim Foundation and the Günther Labes Foundation, the first four Clinical Standards are Open Access and freely available to our global audience of clinicians and healthcare workers.

The series launched with Clinical standards for the assessment, management and rehabilitation of post-TB lung disease followed by Clinical standards for the diagnosis, treatment and prevention of TB infectionClinical standards for the dosing and management of TB drugs and Clinical standards for drug-susceptible pulmonary TB.

The IJTLD is available online

The latest peer-reviewed articles on TB and HIV; respiratory diseases such as asthma and COPD; and the hazards of tobacco and air pollution. Recent coverage has expended to include COVID-19 and the interplay between TB-COVID-19 and other co-morbidities.

Individuals and institutes can subscribe to the IJTLD online or in print – see our Subscription information or e-mail us at subscription@theunion.org for details.

Information for Authors

The 2021 Impact Factor for the IJTLD is 3.4. The Journal presents clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution.

There are no fees for publishing in IJTLD, but authors can choose to pay for articles to be Open Access - see our Journal Publication Charges

Advertising and Sponsorship opportunities

Advertising or sponsoring content is an effective means of reaching clinicians, researchers, health workers, decision makers and students.

Sponsors can support the creation of a Collection or a Supplement on a relevant topic of interest, either in print or a digital collection of articles, for elevated visibility of your products and services.

Other opportunities include being involved in the creation of informative PostersInfographics, or scientific Animations to clarify relevant biological processes. 

IJTLD Fast-Track Articles

In order to share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain accepted articles from the IJTLD and publishing them in full on our website, prior to their publication in the Journal. Read fast-track articles:

Other versions of the journal

The IJTLD has been published in several languages, and publishes the Union World Conference abstract book each year.

Contact

For all IJTLD enquiries, please contact the IJTLD Editorial Office